In total, 227 patients with moderate-to-severe knee OA were scheduled to undergo TKA between July 2018 and July 2019. Fig. 1 is the flow diagram showing the process for inclusion in the analysis. One hundred eighty-three patients (28 men, 155 women) were included in the analysis. Forty-four patients were excluded: one patient had a neurological problem, three patients had a history of surgical treatment for a fracture in the lower extremities, and 40 patients could not give consent.
Among the 183 participants, 46 (25.1%) patients had DM with an HbA1c level of ≤8.0%. Furthermore, 43 (23.5%) patients had an operated knee on the contralateral side. Table 1 summarizes the characteristics of participants with and without DM. Participants with DM were significantly heavier (p=0.001); had a higher BMI (p<0.001) and higher levels of HbA1c (p<0.001), fasting plasma glucose (p<0.001), and triglycerides (p=0.024); and had lower levels of total cholesterol (p=0.032) and HDL cholesterol (p=0.001). No significant differences existed between the two groups in severity of knee OA (i.e., KL grade) and age. Participants with DM had lower knee flexion ROM on the affected and contralateral side (p=0.028 and p=0.039, respectively) and lower knee-extension ROM on the contralateral side (p=0.006). An important finding was that participants with DM had fewer average daily step count (p<0.001) and less time spent in LPA and MVPA (p<0.001, p=0.006, respectively).
Table 1 Summary of the characteristics of knee osteoarthritis participants with and without diabetes mellitus
Variable
|
All
(n = 183)
Mean ± SD or
n (%)
|
Without DM
(n = 137)
Mean ± SD or
n (%)
|
With DM
(n = 46)
Mean ± SD or
n (%)
|
p-value*
|
Demographic characteristic
|
|
|
|
|
Age (y)
|
74.9 ± 6.4
|
74.7 ± 6.6
|
75.4 ± 6.1
|
0.735
|
Sex
|
|
|
|
|
Men
|
28 (15.3)
|
19 (13.9)
|
9 (19.6)
|
0.353
|
Women
|
155 (84.7)
|
118 (86.1)
|
37 (80.4)
|
|
Height (cm)
|
153.2 ± 7.4
|
153.2 ± 7.3
|
153.5 ± 7.9
|
0.999
|
Weight (kg)
|
59.6 ± 10.4
|
58.1 ± 9.8
|
64.1 ± 10.9
|
0.001
|
BMI (kg/m2)
|
25.3 ± 3.5
|
24.7 ± 3.2
|
27.1 ± 3.8
|
<0.001
|
Severity of knee OA
|
|
|
|
|
Kellgren‒Lawrence grade
on affected side (3/4)
|
25/ 158
(13.7/86.3)
|
18/ 119
(13.1/86.9)
|
7/ 39
(15.2/84.8)
|
0.722
|
Kellgren‒Lawrence grade
on contralateral side (2/3/4/operated/unknown)
|
17/35/86/43/2
(9.3/9.1/47.0/23.5/1.1)
|
14/27/64/31/1
(10.2/19.7/46.7/22.6/0.7)
|
3/8/22/12/1
(6.5/17.4/47.8/26.1/2.2)
|
0.836
|
Laboratory data
|
|
|
|
|
HbA1c (%)
|
5.8 ± 0.5
|
5.6 ± 0.3
|
6.4 ± 0.5
|
<0.001
|
Fasting plasma glucose (mg/dl)
|
99.7 ± 25.1
|
94.7 ± 11.9
|
114.6 ± 42.7
|
<0.001
|
Triglycerides (mg/dl)
|
145.8 ± 76.2
|
137.7 ± 68.5
|
169.8 ± 92.4
|
0.024
|
Total cholesterol (mg/dl)
|
197.5 ± 36.5
|
200.7 ± 37.3
|
188.0 ± 32.4
|
0.032
|
HDL cholesterol (mg/dl)
|
59.9 ± 13.4
|
61.5 ± 13.6
|
54.9 ± 11.5
|
0.001
|
LDL cholesterol (mg/dl)
|
111.7 ± 29.4
|
113.2 ± 29.0
|
107.2 ± 30.3
|
0.081
|
Knee function
|
|
|
|
|
Knee flexion ROM (°)
|
|
|
|
|
Affected side
|
130.1 ± 14.0
|
131.3 ± 13.9
|
126.6 ± 13.7
|
0.028
|
Contralateral side
|
129.2 ± 13.6
|
130.4 ± 13.4
|
125.8 ± 13.8
|
0.039
|
Knee-extension ROM (°)
|
|
|
|
|
Affected side
|
-6.4 ± 5.8
|
-6.2 ± 5.7
|
-7.2 ± 5.8
|
0.314
|
Contralateral side
|
-5.1 ± 6.0
|
-4.5 ± 5.9
|
-6.8 ± 6.0
|
0.006
|
Knee-extension muscle strength (Nm/kg)
|
|
|
|
|
Affected side
|
1.03 ± 0.36
|
1.02 ± 0.38
|
1.05 ± 0.32
|
0.619
|
Contralateral side
|
1.16 ± 0.38
|
1.18 ± 0.40
|
1.12 ± 0.33
|
0.356
|
Knee pain, VAS (mm)
|
|
|
|
|
Affected side
|
53.0 ± 25.6
|
53.9 ± 25.3
|
50.2 ± 26.7
|
0.380
|
Contralateral side
|
27.8 ± 25.3
|
28.0 ± 24.8
|
27.3 ± 27.2
|
0.737
|
Performance-based physical function measure
|
|
|
|
|
TUG test time (s)
|
12.8 ± 5.2
|
12.7 ± 4.6
|
13.0 ± 6.5
|
0.964
|
Physical activity
|
|
|
|
|
Average daily step count (steps/day)
|
4275.4 ± 2420.7
|
4656.7 ± 2472.9
|
3122.1 ± 1845.5
|
<0.001
|
Time spent in LPA (min)
|
45.0 ± 24.2
|
49.0 ± 24.6
|
32.9 ± 18.2
|
<0.001
|
Time spent in MVPA (min)
|
4.0 ± 5.1
|
4.5 ± 5.5
|
2.5 ± 3.4
|
0.006
|
BMI Body mass index, OA Osteoarthritis, DM Diabetes mellitus, HbA1c Hemoglobin A1c, HDL High-density lipoprotein, LDL Low-density lipoprotein, ROM Range-of-motion, VAS Visual analog scale, TUG Timed Up-and-Go, LPA Light-intensity physical activity, MVPA Moderate-to-vigorous-intensity physical activity, SD Standard deviation
* Based on unadjusted analysis (Student’s t-test [weight, BMI, HbA1c, and knee-extension muscle strength on both side] or Mann‒Whitney U test [age, height, fasting plasma glucose, triglycerides, total, HDL and LDL cholesterol, knee flexion and extension ROM on both side, knee pain on both side, TUG test time, average daily step count, time spent in LPA, and time spent in MVPA] or the chi-square test [sex]) between OA patients with and without DM. Non-normality of continuous variables was assessed using the Shapiro‒Wilks test (p<0.05); these variables were analyzed using the Mann‒Whitney U test.
Note: The values in bold font indicate statistically significant effects.
Hierarchical multiple linear regression analysis, after adjusting for age, sex, and BMI, revealed that fewer average daily step count was significantly correlated with DM (β = -0.200; p=0.006) and a longer TUG test time (β = -0.196; p=0.014) (Table 2). Furthermore, less time spent in LPA was significantly correlated with DM (β = -0.216; p=0.004) and a longer TUG test time (β = -0.208; p=0.011) (Table 3). Less time spent in MVPA was significantly correlated only with more decreased knee-extension muscle strength on the contralateral side (β = 0.187; p=0.032) (Table 4).
Table 2 Effect of diabetes mellitus on the average daily step count
|
Step 1
|
|
|
|
Step 2
|
|
|
|
B
|
β
|
p-value
|
|
B
|
β
|
p-value
|
Intercept
|
21988.0
|
|
<0.001
|
|
19108.4
|
|
<0.001
|
Age
|
-187.1
|
-0.486
|
<0.001
|
|
-145.3
|
-0.378
|
<0.001
|
Sex (0: men; 1: women)
|
445.8
|
0.066
|
0.361
|
|
406.0
|
0.060
|
0.390
|
BMI
|
-161.8
|
-0.246
|
0.001
|
|
-114.0
|
-0.173
|
0.020
|
DM (0: without DM; 1: with DM)
|
|
|
|
|
-1102.1
|
-0.200
|
0.006
|
TUG test time
|
|
|
|
|
-89.8
|
-0.196
|
0.014
|
Adjusted R2
|
0.237
|
|
0.297
|
BMI Body mass index, DM Diabetes mellitus, TUG Timed Up-and-Go
Note: B is the partial regression coefficient and β is the standardized partial regression coefficient. Bold values indicate a statistically significant effect.
Table 3 Effect of diabetes mellitus on time spent in light-intensity physical activity
|
Step 1
|
|
|
|
Step 2
|
|
|
|
B
|
β
|
p-value
|
|
B
|
β
|
p-value
|
Intercept
|
12140.3
|
|
<0.001
|
|
10308.9
|
|
<0.001
|
Age
|
-97.2
|
-0.424
|
<0.001
|
|
-70.8
|
-0.308
|
<0.001
|
Sex (0: men; 1: women)
|
333.6
|
0.083
|
0.268
|
|
306.7
|
0.076
|
0.291
|
BMI
|
-96.6
|
-0.246
|
0.001
|
|
-65.9
|
-0.168
|
0.028
|
DM (0: without DM; 1: with DM)
|
|
|
|
|
-710.8
|
-0.216
|
0.004
|
TUG test time
|
|
|
|
|
-56.7
|
-0.208
|
0.011
|
Adjusted R2
|
0.187
|
|
0.257
|
BMI Body mass index, DM Diabetes mellitus, TUG Timed Up-and-Go
Note: B is the partial regression coefficient and β is the standardized partial regression coefficient. Bold values indicate a statistically significant effect.
Table 4 Effect of diabetes mellitus on time spent in moderate-to-vigorous-intensity physical activity
|
Step 1
|
|
|
|
Step 2
|
|
|
|
B
|
β
|
p-value
|
|
B
|
β
|
p-value
|
Intercept
|
2385.9
|
|
<0.001
|
|
1809.2
|
|
<0.001
|
Age
|
-24.3
|
-0.501
|
<0.001
|
|
-21.2
|
-0.437
|
<0.001
|
Sex (0: men; 1: women)
|
12.5
|
0.015
|
0.840
|
|
71.8
|
0.084
|
0.284
|
BMI
|
-13.5
|
-0.162
|
0.028
|
|
-8.7
|
-0.105
|
0.176
|
Knee-extension muscle strength on the contralateral side
|
|
|
|
|
149.8
|
0.187
|
0.032
|
Adjusted R2
|
0.230
|
|
0.249
|
BMI Body mass index
Note: B is the partial regression coefficient and β is the standardized partial regression coefficient. Bold values indicate a statistically significant effect.
The VIF was below 10, which indicated that no collinearity existed among the variables and that any significant relationships were not inflated by correlations between the independent variables [35]. Residual plots revealed a random distribution pattern. Independence was observed among the residual errors of average daily step count, time spent in LPA, and time spent in MVPA (the Durbin–Watson statistic was 1.937, 1.912 and 1.936, respectively). These findings indicated that the multivariate regression analysis results in this study were valid.